Academic Health Center
Stay Connected
expert-perspectives

U of M expert: Maximize your health through diet and exercise

Regular exercise is extremely important for people of all ages in order to stay healthy, whether it’s running a marathon or simply setting aside time to power walk a few times per week. But knowing when to eat, what to eat and what exercises are safe at a given age can have a major impact on how someone gains muscle or loses excess fat.

In order to fully understand some variables that impact the effectiveness of a diet and exercise routine, Health Talk consulted David Jewison, M.D. in the Department of Orthopaedic Surgery.

Read more
news-and-notes

University of Minnesota researchers find better time to start HIV therapy

Patients suffering from an AIDS-related infection should start therapy later than expected, according to a new study from the University of Minnesota Medical School.

In a report set to appear in the June 26, 2014, issue of the New England Journal of Medicine, researchers found that waiting 4-6 weeks to start HIV therapy after cryptococcal meningitis diagnosis resulted in 15% better survival than starting HIV therapy 1-2 weeks after diagnosis.

“The overall result is quite surprising. As with every other AIDS-related infection, starting HIV therapy sooner is better,” said the study’s lead author David Boulware, M.D., M.P.H. “It appears that brain infections are different.”

Read more
expert-perspectives

Men’s health: Ganesh Raveendran, M.D., and the fight against heart disease

Heart disease is the top killer of Americans, both men and women, accounting for about one in four deaths each year. From diets high in fat and sugar to a growing sedentary lifestyle, combating heart disease is difficult. To curb this national epidemic, University of Minnesota researcher Ganesh Raveendran, M.D., is working to provide improved cardiac treatment.

Raveendran, director of the cardiac catheterization laboratory at the University of Minnesota Medical School, has conducted multiple studies on regenerative cardiac repair. Throughout his research, Raveendran has worked to find a way to help regrow damaged human hearts.

“If we identify the correct cell population, if we identify the correct dosage of cells, if we identify the correct rate of injection, I think that will make a huge difference in the patients who suffer from heart attack,” Raveendran said.

Read more
research-and-clinical-trials

Master regulator of key cancer gene found, offers new drug target

Gene partnership may be fueling cancer spread in as much as 20 percent of cancers

A key cancer-causing gene, responsible for up to 20 percent of cancers, may have a weak spot in its armor, according to new research from the Masonic Cancer Center, University of Minnesota.

The partnership of MYC, a gene long linked to cancer, and a non-coding RNA, PVT1, could be the key to understanding how MYC fuels cancer cells. The research is published in the latest issue of the journal Nature.

Read more
research-and-clinical-trials

U of M health sciences researchers achieve greatness every day

Every day, more than 1,500 amazing men and women help grow the health sciences programs at the University of Minnesota. These are the faculty of the six schools and colleges that make up the Academic Health Center (AHC), and each has a story to tell.

Through a new video series titled “Every Day,” the AHC is taking viewers inside the lives of our faculty. Just like middle school teachers with a life outside the classroom, our researchers and physicians live exciting lives outside their daily work at the university. Rather than simply profiling their research or clinical specialties, we focus instead on what drives them to make the world a better place.

In this video series, our experts leave their office walls behind and welcome viewers into their personal lives. We encourage you to watch how these researchers better themselves and the world we share together, every day.

Watch the videos here

Read more
in-the-news

In The News: From research to reality

Taking research from the test tube and turning it into treatment for people in need can take a lot of time.

“Making the leap from basic science to a treatment is formidable. The failure rate exceeds 95 percent,” Jeffrey Miller, M.D., and Timothy Schacker, M.D.Medical School wrote in a recent edition of Minnesota Health Care News.

But the degree of success could go up with a newer way of approaching studies, called translational research. The method aims to take discoveries and turn them into practical solutions that can improve the health of people.

Read more